Investing.com - Reneo Pharmaceuticals reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Reneo Pharmaceuticals announced earnings per share of $-0.530 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.578 on revenue of $0.00.
Reneo Pharmaceuticals shares are down 27% from the beginning of the year and are trading at $3.080 , down-from-52-week-high.
Reneo Pharmaceuticals shares gained 1.32% in intra-day trade following the report.
Reneo Pharmaceuticals follows other major Healthcare sector earnings this month
Reneo Pharmaceuticals's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar